Companies

BIOCRYST PHARMACEUTICALS INC (BCRX) SEC filings

CIK 0000882796 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2021
Revenue (USD)
Net income (USD)-182.8 M-108.9 M
Diluted EPS (USD/shares)1.21-1.33

Latest filings

FiledFormDescriptionPeriod
2026-09-024PRIMARY DOCUMENT2026-08-31
2026-09-024PRIMARY DOCUMENT2026-08-31
2026-09-024PRIMARY DOCUMENT2026-08-31
2026-09-024PRIMARY DOCUMENT2026-08-31
2026-09-024PRIMARY DOCUMENT2026-08-31
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-07SCHEDULE 13GSCHEDULE 13G
2026-08-05S-8FORM S-8
2026-08-0510-Q10-Q2026-06-30
2026-08-058-KFORM 8-K items 2.02,7.01,9.012026-08-05
2026-08-048-K/AFORM 8-K/A items 2.052026-06-25
2026-06-298-KFORM 8-K items 2.05,7.01,9.012026-06-25
2026-06-154PRIMARY DOCUMENT2026-06-11
2026-06-154PRIMARY DOCUMENT2026-06-11
2026-06-154PRIMARY DOCUMENT2026-06-11
2026-06-154PRIMARY DOCUMENT2026-06-11
2026-06-154PRIMARY DOCUMENT2026-06-11
2026-06-154PRIMARY DOCUMENT2026-06-11
2026-06-154PRIMARY DOCUMENT2026-06-11
2026-06-154PRIMARY DOCUMENT2026-06-11
2026-06-154PRIMARY DOCUMENT2026-06-11
2026-06-128-KFORM 8-K items 5.02,5.07,9.012026-06-11
2026-06-024PRIMARY DOCUMENT2026-05-29
2026-06-024PRIMARY DOCUMENT2026-05-29
2026-06-024PRIMARY DOCUMENT2026-05-29

Forms on file (last 1,000): 4 480, 8-K 195, SC 13G/A 56, 425 45, 10-Q 32, SC 13G 21, 144 20, S-8 19. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=BCRX (0.002 USD), /gw/filings/filings?ticker=BCRX&form=8-K, /gw/filings/facts?ticker=BCRX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange